previous compound ID: 2602 next compound
InChIKey: XLFWDASMENKTKL-UHFFFAOYSA-N
SMILES: CCO/C(=N/C1=C[N+](=NO1)N2CCOCC2)/[O-]

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "DY Thomas" "SD Macknight" "R Robert" "E Matthes" "J Goepp" "JW Hanrahan" "J Liao" "D Rotin" "B Kus"

chemical graph of compound 2602





CID is 4238
synonyms found at PubChem are:
25717-80-0, Molsidomin, N-(Ethoxycarbonyl)-3-(4-morpholinyl)sydnone imine, AC1L1HPV, CHEBI:31861, CTK8E8012, KS-00001FAH, MolPort-023-220-276, XLFWDASMENKTKL-NTMALXAHSA-N, HMS3369H14, HMS3373B04, AKOS030254869, LP00725, H532, M2524, 1-ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate, (Z)-5-(ethoxycarbonylimino)-3-morpholino-5H-1,2,3-oxadiazol-3-ium-2-ide, molsidomine, morsydomine, Corvaton, Molsidolat, Motazomin, SIN-10, Sydnopharm, Morial, N-Ethoxycarbonyl-3-morpholinosydnonimine, Molsidominum [INN-Latin], Molsidomina [INN-Spanish], MLS000028573, UNII-D46583G77X, CAS 276, EINECS 247-207-4, BRN 3999414, SMR000058990, Sydnone imine, N-(ethoxycarbonyl)-3-(4-morpholinyl)-, N-Carboxy-3-morpholinosydnonimine ethyl ester, N-Carboxy-3-morpholinosydnone imine ethyl ester, N-(Ethoxycarbonyl)-3-(4-morpholino)sydnone imine, Corvasal, Coruno, Sydnone imine, N-carboxy-3-morpholino-, ethyl ester, D46583G77X, NCGC00015661-02, CAS-25717-80-0, DSSTox_CID_25171, DSSTox_RID_80721, DSSTox_GSID_45171, Molsidomina, Molsidominum, Covarsal, Korvatone, (1E)-1-ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate, (1E)-1-ethoxy-N-(3-morpholin-4-yl-1,2,3-oxadiazol-3-ium-5-yl)methanimidate, (1E)-1-ethoxy-N-[3-(4-morpholinyl)-5-oxadiazol-3-iumyl]methanimidate, SR-05000001464, N-Carboxy-3-morpholinosynonimine ethyl ester, Corraton, ethyl (NZ)-N-(3-morpholin-4-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-ylidene)carbamate, Molsidomine [USAN:BAN:INN:JAN], Molsidomine [USAN:INN:BAN:JAN], Prestwick_863, Opera_ID_238, AC1NS4KW, Prestwick3_000547, Lopac-M-2901, SIN 10 (pharmaceutical), SCHEMBL34019, BSPBio_000593, MLS001146942, MLS002153869, SPECTRUM1500673, Molsidomine (JAN/USAN/INN), BPBio1_000653, CHEMBL1256353, CHEMBL1329455, DTXSID0045171, BDBM39912, CHEBI:92623, cid_5353788, HMS501O05, MolPort-003-666-317, MolPort-005-937-659, MolPort-009-684-981, MolPort-035-394-902, HMS1569N15, HMS1921A16, HMS2089L03, HMS2092G20, HMS2096N15, HMS2232F20, HMS2235B12, HMS3262A12, HMS3649M16, HMS3713N15, HY-B1069, Molsidomine 1.0 mg/ml in Methanol, Tox21_110192, Tox21_500725, CCG-40069, MFCD00869301, s4664, 5-[(Ethoxycarbonyl)amino]-3-(4-morpholinyl)-1,2,3-oxadiazolium Inner Salt, AKOS015843340, AKOS015900360, AKOS015962928, AKOS026749793, Tox21_110192_1, AC-7473, AN-8958, CCG-220547, CS-4625, DB09282, KS-5160, MCULE-1835289527, ACM25717800, NCGC00015661-01, NCGC00015661-03, NCGC00015661-04, NCGC00015661-05, NCGC00015661-06, NCGC00015661-07, NCGC00015661-08, NCGC00015661-09, NCGC00015661-10, NCGC00015661-12, NCGC00024136-03, NCGC00024136-04, NCGC00024136-05, NCGC00024136-06, NCGC00024136-07, NCGC00261410-01, SC-15261, SMR001233224, SBI-0050703.P004, LS-148340, TC-064031, AB00513859, EU-0100725, N-(Ethoxycarbonyl)-3-morpholinosydnone imine, ST51015046, D01320, K-6715, AB00052152_14, AB00513859-02, A817988, I14-0398, SR-05000001464-1, SR-05000001464-3, W-107222, ethoxy-N-(3-morpholin-4-yl(1,2,3-oxadiazol-5-yl))carboxamide, (1E)-1-ethoxy-N-(3-morpholinooxadiazol-3-ium-5-yl)formimidate, (1E)-1-ethoxy-N-(3-morpholinooxadiazol-3-ium-5-yl)methanimidate, Ethyl (3-morpholin-4-yl-1-oxa-2-aza-3-azoniacyclopenta-2,4-dien-5-yl)aminoformate, AC1NSES5, Pharmakon1600-01500673, NSC757398, NSC-757398, NCGC00179510-01, BRD-K35531059-001-02-4, (1Z)-1-ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate